Skip to content

An Innovative Silicone Wound Dressing for the Management of Atrophic Vaginitis

Efficacy and Safety of a Novel Silicone Wound Dressing for the Management of Atrophic Vaginitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05432154
Enrollment
10
Registered
2022-06-27
Start date
2022-04-01
Completion date
2022-07-31
Last updated
2022-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic Vaginitis

Brief summary

The objective of the study is to determine the efficacy of 7-0940 in the management of atrophic vaginitis in female patients

Interventions

Film forming silicone gel (7-0940) is an innovative gel that forms a full contact, flexible wound dressing for supporting mucosal conditions of the genital, rectal and perineal areas. Film forming silicone gel (7-0940) is a semi-occlusive, non-resorbable, self-drying and transparent gel. Film forming silicone gel (7-0940) may be directly applied to dry, wet, cracked and sensitive mucosal tissue. Film forming silicone gel (7-0940) gel is bacteriostatic and inert. It contains no alcohols, parabens or fragrances.

Sponsors

Stratpharma AG
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Able to provide informed consent * Diagnosed acute or chronic Atrophic Vaginitis * Controlled disease, or uncontrolled disease that did not respond to standard therapy with HRT

Exclusion criteria

* Unable to provide informed consent * Patient unable to apply topical device * Allergy or intolerance to ingredients or excipients of the formulation of studied products * Currently on HRT (orally or topically) * Currently on corticosteroid treatment

Design outcomes

Primary

MeasureTime frameDescription
Patient-reported Vulvar Quality of Life3 monthsVulvar Quality of Life Index

Secondary

MeasureTime frameDescription
Patient-reported symptoms3 monthsLikert scales to measure: * Pruritus/itchiness * Tender/sore * Swelling * Dryness * Burning of skin * Dyspareunia * Stinging with urination/clothes * Defecating pain/burning
Severity of overall condition3 monthsClinician-rated severity of atrophic vaginitis
Product rating3 monthsLikert scale for product rating by the patient

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026